1. Poston JT, Koyner JL (2019): Sepsis associated acute kidney injury. BMJ 364: k4891.
2.
Hoste EAJ, Kellum JA, Selby NM (2018): Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 14: 607-625.
3.
Zarbock A, Nadim MK, Pickkers P, et al. (2023): Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol 19: 401-417.
4.
Peerapornratana S, Manrique-Caballero CL, Gómez H, et al. (2019): Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 96: 1083-1099.
5.
Privratsky JR, Ide S, Chen Y, et al. (2023): A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury. Kidney Int 103: 514-528.
6.
Wang X, Ding Y, Li R, et al. (2023): N(6)-methyladenosine of Spi2a attenuates inflammation and sepsis-associated myocardial dysfunction in mice. Nat Commun 14: 1185.
7.
Hoesel B, Schmid JA (2013): The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 12: 86.
8.
Taniguchi K, Karin M (2018): NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18: 309-324.
9.
Kauppinen A, Suuronen T, Ojala J, et al. (2013): Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25: 1939-1948.
10.
Li C, Li L, Chen K, et al. (2019): UFL1 alleviates lipopolysaccharide-induced cell damage and inflammation via regulation of the TLR4/NF-κB pathway in bovine mammary epithelial cells. Oxid Med Cell Longev 2019: 6505373.
11.
Li K, Lv G, Pan L (2018): Sirt1 alleviates LPS induced inflammation of periodontal ligament fibroblasts via downregulation of TLR4. Int J Biol Macromol 119: 249-254.
12.
Zhou R, Hu G, Gong AY, et al. (2010): Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res 38: 3222-3232.
13.
Liu Z, Tang C, He L, et al. (2020): The negative feedback loop of NF-κB/miR-376b/NFKBIZ in septic acute kidney injury. JCI Insight 5: e142272.
14.
Feng Y, Liu J, Wu R, et al. (2020): NEAT1 aggravates sepsis-induced acute kidney injury by sponging miR-22-3p. Open Med (Wars) 15: 333-342.
15.
Gaid M, Biedermann E, Füller J, et al. (2018): Biotechnological production of hyperforin for pharmaceutical formulation. Eur J Pharm Biopharm 126: 10-26.
16.
Yao H, Zhang Y, Shu H, et al. (2019): Hyperforin promotes post-stroke neuroangiogenesis via astrocytic IL-6-mediated negative immune regulation in the ischemic brain. Front Cell Neurosci 13: 201.
17.
Quiney C, Billard C, Salanoubat C, et al. (2006): Hyperforin, a new lead compound against the progression of cancer and leukemia? Leukemia 20: 1519-1525.
18.
El Hamdaoui Y, Zheng F, Fritz N, et al. (2022): Analysis of hyperforin (St. John’s wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs. Mol Psychiatry 27: 5070-5085.
19.
Shinjyo N, Nakayama H, Li L, et al. (2021): Hypericum perforatum extract and hyperforin inhibit the growth of neurotropic parasite Toxoplasma gondii and infection-induced inflammatory responses of glial cells in vitro. J Ethnopharmacol 267: 113525.
20.
Novelli M, Masiello P, Beffy P, et al. (2020): Protective role of St. John’s wort and its components hyperforin and hypericin against diabetes through inhibition of inflammatory signaling: evidence from in vitro and in vivo studies. Int J Mol Sci 21: 8108.
21.
Hohmann MS, Cardoso RD, Fattori V, et al. (2015): Hypericum perforatum reduces paracetamol-induced hepatotoxicity and lethality in mice by modulating inflammation and oxidative stress. Phytother Res 29: 1097-1101.
22.
Meinke MC, Schanzer S, Haag SF, et al. (2012): In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo. Eur J Pharm Biopharm 81: 346-350.
23.
Yang S, Zhong S, Deng Z, et al. (2023): Hyperforin regulates renal fibrosis via targeting the PI3K-AKT/ICAM1 axis. Cell Signal 108: 110691.
24.
Han P, Weng W, Chen Y, et al. (2020): Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice. Am J Transl Res 12: 5015-5031.
25.
Zhang Y, Kong J, Deb DK, et al. (2010): Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol 21: 966-973.
26.
Yu X, Meng X, Xu M, et al. (2018): Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function. EBioMedicine 36: 266-280.
27.
Novelli M, Menegazzi M, Beffy P, et al. (2016): St. John’s wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic cells. Int J Biochem Cell Biol 81: 92-104.
28.
Novelli M, Beffy P, Gregorelli A, et al. (2019): Persistence of STAT-1 inhibition and induction of cytokine resistance in pancreatic cells treated with St John’s wort and its component hyperforin. J Pharm Pharmacol 71: 93-103.
29.
Jiang X, Kumar M, Zhu Y (2018): Protective effect of hyperforin on amyloid protein induced apoptosis in PC12 cells and colchicine induced Alzheimer’s disease: an anti-oxidant and anti-inflammatory therapy. J Oleo Sci 67: 1443-1453.
30.
Mann M, Mehta A, Zhao JL, et al. (2017): An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses. Nat Commun 8: 851.
31.
Xie M, Wang J, Gong W, et al. (2019): NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3. J Autoimmun 102: 96-113.
32.
Hübner K, Karwelat D, Pietsch E, et al. (2020): NF-κB-mediated inhibition of microRNA-149-5p regulates Chitinase-3-like 1 expression in human airway epithelial cells. Cell Signal 67: 109498.
33.
Ding X, Jing N, Shen A, et al. (2021): MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20. J Endocrinol Invest 44: 1175-1184.
34.
Kölling M, Kaucsar T, Schauerte C, et al. (2017): Therapeutic miR-21 silencing ameliorates diabetic kidney disease in mice. Mol Ther 25: 165-180.
35.
Lange T, Artelt N, Kindt F, et al. (2019): MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury. J Cell Mol Med 23: 4839-4843.
36.
Wang S, Wang J, Zhang Z, et al. (2017): Decreased miR-128 and increased miR-21 synergistically cause podocyte injury in sepsis. J Nephrol 30: 543-550.
